Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 11:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–11 of 11 matching trials from the live ClinicalTrials.gov search.

Conditions: Acne
Interventions: Adapalene/BPO Gel, Moisturizer SPF 30, Foam Wash; Drug · Other
Lead sponsor: Galderma R&D; Industry
Eligibility: 9 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 5
States / cities: Boynton Beach, Florida • Nashville, Tennessee • Carrollton, Texas + 2 more

Conditions: Acne
Interventions: Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel, Vehicle Gel; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 12 Years to 35 Years
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 27
States / cities: San Diego, California • Denver, Colorado • Longmont, Colorado + 24 more

Conditions: Acne Vulgaris
Interventions: Clindamycin and benzoyl peroxide, benzoyl peroxide 2.5% and adapalene 0.1% gel; Drug
Lead sponsor: Stiefel, a GSK Company; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Broomall, Pennsylvania

Conditions: Acne Vulgaris
Interventions: Adapalene BPO; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 12 Years to 35 Years
Enrollment: 272 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 4
States / cities: Santa Monica, California • Fridley, Minnesota • Albuquerque, New Mexico + 1 more

Conditions: Acne
Interventions: clindamycin phosphate 1.2%/adapalene 0.15%/BPO 3.1% gel, adapalene 0.3%/BPO 2.5% gel and compounded clindamycin phosphate 1.2% gel, Compounded BPO 2.5% gel, adapalene 0.1% gel, and compounded clindamycin phosphate 1.2% gel; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 85 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Severe Acne Vulgaris
Interventions: Adapalene BPO Gel associated with Doxycyline Hyclate, Vehicle Gel associated with Doxycycline Hyclate; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 12 Years to 35 Years
Enrollment: 459 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 28
States / cities: Oceanside, California • San Diego, California • Denver, Colorado + 25 more

Conditions: Acne Vulgaris
Interventions: IDP-126 Gel, IDP-126 Vehicle Gel, Epiduo® Forte Gel; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 12 Years to 99 Years
Enrollment: 686 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 34
States / cities: Bryant, Arkansas • Rogers, Arkansas • Fremont, California + 27 more

Conditions: Acne Vulgaris
Interventions: CABTREO is a fixed-combination product of clindamycin phosphate 1.2%/BPO 3.1%/adapalene 0.15%.; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 9 Years to 11 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 15
States / cities: Bryant, Arkansas • Rogers, Arkansas • Freemont, California + 12 more

Search by objective public record fields.